Royce & Associates LP Haemonetics Corp Transaction History

Royce & Associates LP

$9.25 Billion
Q2 2025

A detailed history of Royce & Associates LP transactions in Haemonetics Corp stock. As of the latest transaction made, Royce & Associates LP holds 1,271,057 shares of HAE stock, worth $65.3 Million. This represents 1.03% of its overall portfolio holdings.

Number of Shares

1,271,057

Previous 1,161,296 9.45%

Holding current value

$65.3 Million

Previous $73.8 Million 28.5%

% of portfolio

1.03%

Previous 0.84%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 11, 2025	BUY	$56.04 - $74.77 $6.15 Million - $8.21 Million	109,761 Added 9.45%	1,271,057 $94.8 Million
Q1 2025 May 06, 2025	BUY	$59.34 - $80.05 $476,381 - $642,641	8,028 Added 0.7%	1,161,296 $73.8 Million
Q4 2024 Feb 10, 2025	SELL	$71.16 - $93.38 $4.08 Million - $5.35 Million	-57,278 Reduced 4.73%	1,153,268 $90 Million
Q3 2024 Nov 06, 2024	BUY	$72.45 - $91.58 $2.24 Million - $2.83 Million	30,868 Added 2.62%	1,210,546 $97.3 Million
Q2 2024 Aug 13, 2024	SELL	$81.24 - $97.37 $7.06 Million - $8.46 Million	-86,936 Reduced 6.86%	1,179,678 $97.6 Million
Q1 2024 May 13, 2024	BUY	$71.24 - $85.35 $21.4 Million - $25.6 Million	300,259 Added 31.07%	1,266,614 $108 Million
Q4 2023 Feb 12, 2024	BUY	$80.59 - $92.61 $1.52 Million - $1.74 Million	18,805 Added 1.98%	966,355 $82.6 Million
Q3 2023 Nov 09, 2023	BUY	$82.56 - $93.49 $3.41 Million - $3.86 Million	41,258 Added 4.55%	947,550 $84.9 Million
Q2 2023 Aug 07, 2023	BUY	$80.84 - $89.45 $5.06 Million - $5.59 Million	62,538 Added 7.41%	906,292 $77.2 Million
Q1 2023 May 04, 2023	BUY	$72.75 - $90.6 $1.33 Million - $1.66 Million	18,292 Added 2.22%	843,754 $69.8 Million
Q4 2022 May 23, 2023	SELL	$73.85 - $86.14 $1.35 Million - $1.58 Million	-18,292 Reduced 2.17%	825,462 $64.9 Million
Q4 2022 Feb 13, 2023	SELL	$73.85 - $86.14 $3.64 Million - $4.25 Million	-49,346 Reduced 5.64%	825,462 $64.9 Million
Q3 2022 Nov 03, 2022	BUY	$63.3 - $78.66 $2.1 Million - $2.61 Million	33,223 Added 3.95%	874,808 $64.8 Million
Q2 2022 Aug 04, 2022	BUY	$49.27 - $66.08 $4.16 Million - $5.57 Million	84,341 Added 11.14%	841,585 $54.9 Million
Q1 2022 May 05, 2022	BUY	$43.77 - $63.22 $2.15 Million - $3.11 Million	49,136 Added 6.94%	757,244 $47.9 Million
Q4 2021 Feb 07, 2022	SELL	$49.55 - $74.59 $13.7 Million - $20.6 Million	-276,250 Reduced 28.06%	708,108 $37.6 Million
Q3 2021 Nov 10, 2021	BUY	$57.6 - $70.59 $22 Million - $27 Million	382,812 Added 63.64%	984,358 $69.5 Million
Q2 2021 Aug 06, 2021	BUY	$51.81 - $118.56 $6.89 Million - $15.8 Million	132,961 Added 28.38%	601,546 $40.1 Million
Q1 2021 May 10, 2021	SELL	$111.01 - $139.48 $14.5 Million - $18.2 Million	-130,171 Reduced 21.74%	468,585 $52 Million
Q4 2020 Feb 08, 2021	BUY	$88.75 - $119.95 $1.34 Million - $1.82 Million	15,148 Added 2.6%	598,756 $71.1 Million
Q3 2020 Nov 12, 2020	BUY	$75.65 - $93.58 $6.84 Million - $8.46 Million	90,415 Added 18.33%	583,608 $50.9 Million
Q2 2020 Aug 07, 2020	BUY	$84.96 - $118.91 $9.91 Million - $13.9 Million	116,588 Added 30.96%	493,193 $44.2 Million
Q1 2020 May 12, 2020	BUY	$74.34 - $121.82 $25.8 Million - $42.2 Million	346,436 Added 1148.32%	376,605 $37.5 Million
Q4 2019 Feb 06, 2020	BUY	$114.37 - $129.46 $3.45 Million - $3.91 Million	30,169 New	30,169 $3.47 Million
Q3 2018 Nov 13, 2018	SELL	$89.96 - $114.58 $1.74 Million - $2.21 Million	-19,300 Closed	0 $0
Q2 2018 Aug 09, 2018	SELL	$71.53 - $95.75 $50,071 - $67,025	-700 Reduced 3.5%	19,300 $1.73 Million
Q1 2018 May 14, 2018	BUY	$60.72 - $74.41 $1.2 Million - $1.47 Million	19,792 Added 9515.38%	20,000 $1.46 Million
Q4 2017 Feb 09, 2018	SELL	$44.96 - $58.99 $1,843 - $2,418	-41 Reduced 16.47%	208 $12,000
Q3 2017 Nov 13, 2017	BUY	$40.38 - $44.87 $10,054 - $11,172	249	249 $11,000

Others Institutions Holding HAE

# of Institutions

336

Shares Held

53.4M

Call Options Held

540K

Put Options Held

306K

View Full List

About HAEMONETICS CORP

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $2.64B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

More about HAE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royce & Associates LP, based on Form 13F filings with the SEC.

News

Stay updated on Royce & Associates LP with notifications on news.

Account

Royce & Associates LP Haemonetics Corp Transaction History